Mark Diamond

Mark Diamond

Presidente presso DIMERIX LIMITED
Health Technology
Consumer Services
Distribution Services

Profilo

Mark Diamond is currently Non-Executive Chairman at Dimerix Ltd. since 2023 and Non-Executive Director at Arovella Therapeutics Ltd. starting in 2026.
Former roles include Chief Executive Officer & Executive Director at Percheron Therapeutics Ltd. from 2010 to 2023, Director-Project Planning & Business Development at Alpharma Specialty Pharma LLC, Manager-International Business Development at FH Faulding & Co. Ltd., and Senior Manager-Business Development at Faulding Pharmaceuticals Plc.
Education includes an undergraduate degree from Monash University and an MBA from Macquarie University.

Posizioni attive di Mark Diamond

SocietàPosizioneInizio
DIMERIX LIMITED Presidente 12/01/2023
AROVELLA THERAPEUTICS LIMITED Direttore/Membro del Consiglio 28/04/2026

Precedenti posizioni note di Mark Diamond

SocietàPosizioneFine
PERCHERON THERAPEUTICS LIMITED Amministratore Delegato 12/05/2023
Corporate Officer/Principal -
Faulding Pharmaceuticals Plc
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark Diamond

Formazione di Mark Diamond

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

17

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Faulding Pharmaceuticals Plc

  1. Mercati
  2. Insiders
  3. Mark Diamond
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA